Home › NDC Lookup › RxCUI directory › RxCUI 238542

Methyl salicylate 250 MG/ML Topical Cream — RxCUI 238542

RxNorm drug concept · Semantic clinical drug
RxCUI 238542 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 15 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI238542
Official nameMethyl salicylate 250 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethyl salicylate 25 % Topical Cream
FDA products mapped13
Package NDCs mapped15
Reported Medicaid activity (SDUD)282 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methyl Salicylate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a topical pain reliever — you apply it right to the skin where it hurts. It's used for temporary relief of minor aches and pains in your muscles and joints, things like arthri...
  • What is methyl salicylate actually used for?
  • No — and this is really important. You should never use methyl salicylate products with a heating pad, and avoid applying them when you're sweating from exercise or heat. Heat caus...
  • Is it safe to use under a heating pad or wrap?
📖 Read our full Methyl Salicylate guide →

🕸️ Concept Web — How Methyl salicylate 250 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methyl salicylate 250 MG/ML Topical Cream RxCUI 238542

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methyl salicylate 29787
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methyl salicylate Topical Cream 377908
    • Methyl salicylate Topical Product 1156734
    • Topical Cream 316982
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Methyl salicylate 250 MG/ML 343454

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methyl salicylate 250 MG/ML SCDC · 343454
  • Methyl salicylate Topical Cream SCDF · 377908
  • Methyl salicylate Topical Product SCDG · 1156734

📦 FDA Products & Package NDCs

13 products · 15 package NDCs
15 package NDCs map to RxCUI 238542 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10096-4001-01 1 TUBE in 1 CARTON (10096-4001-1) / 75 mL in 1 TUBE AVON footworks Arthritis Achy Foot and Muscle The Avon Company 2024-08-01
50488-1015-01 120 g in 1 BOTTLE (50488-1015-1) Methyl Salicylate Alexso, Inc 2019-04-01
50488-1015-05 50 g in 1 BOTTLE (50488-1015-5) Methyl Salicylate Alexso, Inc 2019-04-01
50488-1016-05 50 mL in 1 BOTTLE, PUMP (50488-1016-5) Methyl Salicylate 25 Percent Alexso, Inc 2024-05-01
59088-0014-06 60 g in 1 JAR (59088-014-06) Methyl Salicylate 25% Pain Relieving Puretek Corporation 2025-06-12
59088-0245-06 60 g in 1 JAR (59088-245-06) Methylten 25% Pain Relieving PureTek Corporation 2025-06-12
73492-0273-60 1 TUBE in 1 CARTON (73492-273-60) / 60 g in 1 TUBE Methyl Salicylate ALAINA HEALTHCARE PRIVATE LIMITED 2025-05-13
79643-0004-01 100 g in 1 TUBE (79643-004-01) Methyl Salicylate PHARMACURE LLC 2024-05-01
80425-0544-01 120 g in 1 TUBE (80425-0544-1) Methyl Salicylate 25% Cream Advanced Rx of Tennessee, LLC 2025-08-08
82461-0415-05 50 mL in 1 BOTTLE, PUMP (82461-415-05) Methyl Salicylate 25% Cream Medcore LLC 2025-07-14
82461-0415-10 120 mL in 1 BOTTLE, PUMP (82461-415-10) Methyl Salicylate 25% Cream Medcore LLC 2025-02-14
85096-0001-42 120 g in 1 TUBE (85096-001-42) Methyl Salicylate 25% Cream MARCELLA HEALTH 2025-04-15
85231-0201-60 1 TUBE in 1 CARTON (85231-201-60) / 60 g in 1 TUBE Methyl Salicylate ViolaCare, Inc. 2025-06-02
85477-0301-10 118 mL in 1 BOTTLE, PUMP (85477-301-10) METHYL SALICYLATE 25% Oncora Pharma, LLC 2025-06-11
85477-0311-10 120 g in 1 TUBE (85477-311-10) METHYL SALICYLATE 25% Oncora Pharma, LLC 2025-08-08
Observed labelers: Alexso, Inc (3) · Medcore LLC (2) · Oncora Pharma, LLC (2) · Puretek Corporation (2) · Advanced Rx of Tennessee, LLC (1) · ALAINA HEALTHCARE PRIVATE LIMITED (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.